首页> 外文期刊>Journal of intensive care medicine >Management of Acute Myeloid Leukemia in the Intensive Care Setting.
【24h】

Management of Acute Myeloid Leukemia in the Intensive Care Setting.

机译:重症监护环境中急性髓细胞白血病的管理。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with acute myeloid leukemia (AML) who are newly diagnosed or relapsed and those who are receiving cytotoxic chemotherapy are predisposed to conditions such as sepsis due to bacterial and fungal infections, coagulopathies, hemorrhage, metabolic abnormalities, and respiratory and renal failure. These conditions are common reasons for patients with AML to be managed in the intensive care unit (ICU). For patients with AML in the ICU, providers need to be aware of common problems and how to manage them. Understanding the pathophysiology of complications and the recent advances in risk stratification as well as newer therapy for AML are relevant to the critical care provider.
机译:新诊断或复发的急性髓细胞性白血病(AML)患者以及接受细胞毒性化学疗法的患者因细菌和真菌感染,凝血病,出血,代谢异常以及呼吸和肾衰竭而易感败血症。这些情况是重症监护病房(ICU)应对AML患者进行治疗的常见原因。对于ICU中的AML患者,提供者需要了解常见问题以及如何解决这些问题。了解并发症的病理生理学和风险分层的最新进展以及针对AML的新疗法与重症监护提供者有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号